HWCPZ Q1 2026 Earnings Slight EPS Beat Highlights Steady Performance Armata Pharmaceuticals ARMP Q1 2026 Earnings Massive EPS Miss as PreRevenue Biotech Struggles with Costs C3ai Q1 2026 Earnings EPS Misses Estimates as Loss Widens NMRA Q1 2026 Earnings NarrowerthanExpected Loss Reflects Operational Discipline UNMA Q1 2026 Earnings Unum Group Beats EPS Estimates Notes Stable PRH Q1 2026 Earnings EPS Surges 154 Above Estimates Positive Market Response